Login / Signup

AMPK-SP1-Guided Dynein Expression Represents a New Energy-Responsive Mechanism and Therapeutic Target for Diabetic Nephropathy.

Jillian WilliquettChantal AllamargotHua Sun
Published in: Kidney360 (2024)
Keyphrases
  • diabetic nephropathy
  • poor prognosis
  • skeletal muscle
  • cancer therapy
  • binding protein
  • long non coding rna